title: What is the most useful and cost-effective strategy to screen for left ventricular systolic dysfunction in clinical practice?
authors.forename: Ayako
authors.initials: A
authors.lastname: Yamada
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Yamada
authors.forename: Keiji
authors.initials: K
authors.lastname: Okada
mesh_terms: D015415:Biomarkers / Q000097:blood; D003362:Cost-Benefit Analysis; D004452:Echocardiography / Q000191:economics; D004562:Electrocardiography / Q000191:economics; D006801:Humans; D008403:Mass Screening / Q000191:economics; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis*
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain